Benzodiazepines in clinical practice : risks and benefits
著者
書誌事項
Benzodiazepines in clinical practice : risks and benefits
(Clinical practice, no. 17)
American Psychiatric Press, c1991
大学図書館所蔵 全4件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references
内容説明・目次
内容説明
Many physicians are reluctant to prescribe benzodiazepines for fear that patients will become addicted. This book is designed to help practicing physicians make rational, carefully considered assessments of the risks and benefits of using benzodiazepines in the treatment of their patients. The book sheds light on this controversial area by presenting results of scientific studies and well-controlled treatment trials. This volume is divided into four sections. In the first section, recent findings of basic scientists regarding the action of benzodiazepines in the brain are presented to provide essential background for understanding their clinical effects. A chapter about pharmacokinetics and pharmacodynamics gives a rational basis for the choice of a particular benzodiazepine in a given clinical situation. In the second section four chapters discuss indications for and the efficacy of benzodiazepines in specific disorders within the general areas of anxiety and depression, adjustment and stress syndromes, psychosis, and sleep disorders. The third section discusses risks of benzodiazepines, including psychomotor and cognitive effects, dependence and withdrawal and abuse liability.
Information regarding those patients or treatment regimens with the greatest risk of these adverse effects is presented. To conclude, the fourth section considers special populations and issues, including treatment of the elderly and medically ill and the use of benzodiazepines in combination with psychotherapy.
目次
- Part 1 Scientific basis: benzodiazepines - biological mechanisms, Peter P. Roy-Byrne, David J.Nutt
- benzodiazepines - pharmacokinetics and pharmacodynamics, Deborah S.Cowley, Peter P.Roy-Byrne, et al. Part 2 Uses and indications: benzodiazepines in anxiety and depression, Deborah S. Cowley, David L. Dunner
- benzodiazepines in psychotic and related conditions, Seth Cohen
- benzodiazepines in acute stress reactions - benefits, risks and controversies, Peter Forster, Charles R. Marmar. Part 3 Risks and benefits: benzodiazepines - cognitive and psychomotor effects, Daniel W. Hommer
- benzodiazepines - dependence and withdrawal, Peter P. Roy-Byrne
- benzodiazepines abuse liability, Domenic A. Ciraulo, Ofra Sarid-Segal. Part 4 Special populations and issues: use of benzodiazepines in the medically ill, Francisco Fernandez, Joel K. Levy
- interactions of benzodiazepines in the elderly, Brian A. Lawlor, Trey Sunderland.
「Nielsen BookData」 より